MAGNASCO, LAURA
 Distribuzione geografica
Continente #
EU - Europa 2.983
AS - Asia 46
SA - Sud America 5
NA - Nord America 2
Totale 3.036
Nazione #
IT - Italia 2.983
CN - Cina 36
VN - Vietnam 8
BR - Brasile 3
SG - Singapore 2
US - Stati Uniti d'America 2
AR - Argentina 1
EC - Ecuador 1
Totale 3.036
Città #
Genoa 1.593
Genova 547
Rapallo 449
Vado Ligure 372
Beijing 19
Bordighera 16
Ashburn 2
Hanoi 2
Ho Chi Minh City 2
Milan 2
Treviglio 2
Verona 2
Ha Long 1
Hải Dương 1
Porto Alegre 1
Quito 1
Reconquista 1
Singapore 1
São Paulo 1
Tangshan 1
Thái Nguyên 1
Totale 3.017
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 262
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 160
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 155
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 148
Bloodstream infections in critically ill patients with COVID-19 142
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 131
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 126
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 116
Variazioni del filtrato glomerulare (eGFR) in una coorte di pazienti nati con HIV, risultati di uno studio osservazionale dal 2009 al 2018 102
Loss to follow-up and re-linkage to care in a single cohort study: who do we re-link to care? 101
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 90
Cause di ricovero ed outcome del paziente con infezione da HIV nei reparti di terapia intensiva 85
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 82
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 82
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 81
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 78
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 73
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 71
Duration of isolation and precautions in immunocompromised patients with COVID-19 71
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 70
Molecular epidemiological investigation of a nosocomial cluster of c. Auris: Evidence of recent emergence in italy and ease of transmission during the covid‐19 pandemic 68
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa 67
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 66
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 65
Response to letter to the editor: switch to dolutegravir and unboosted atazanavir 63
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 61
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit 59
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 55
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 55
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV 53
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains 49
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges? 49
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic 40
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 36
Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials 32
The Role of PCSK9 in Infectious Diseases 22
Recent advances and future perspectives in the pharmacological treatment of Candida auris infections 14
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infections 12
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study) 12
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common? 10
Totale 3.114
Categoria #
all - tutte 15.518
article - articoli 15.172
book - libri 0
conference - conferenze 346
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 15 4 42 20 32 22 18 5
2021/2022273 22 7 5 28 21 9 13 52 16 40 22 38
2022/2023552 39 50 5 41 56 56 38 33 89 67 59 19
2023/2024358 26 32 6 46 25 56 24 28 21 11 38 45
2024/20251.016 30 64 19 69 124 95 109 220 39 56 108 83
2025/2026601 229 51 185 136 0 0 0 0 0 0 0 0
Totale 3.114